Based on these findings, we hypothesized that in vivo selection of developing tumor clones would be associated with the ability of tumor cells to overexpress the IFN/STAT1 pathway while resisting IFNγ-mediated cytotoxicity. Here, STAT1 is linked to neoplasm.